Yongqiang Xie
P.R. China
Baiyin, 730900, China
Baiyin, 730900, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Novel therapeutic strategies for metastatic castration‑resistant prostate cancer: Beyond androgen receptor pathway inhibition (Review).
Journal: International journal of oncology
Published: December 26, 2025
Targeted therapies for urothelial carcinoma: From FGFR inhibitors to next‑generation antibody-drug conjugates (Review).
Journal: International journal of oncology
Published: September 14, 2025
Gut microbiota as a multifaceted modulator of prostate cancer: Mechanistic insights, therapeutic opportunities and clinical challenges (Review).
Journal: Molecular medicine reports
Published: July 30, 2025
The Application of Prostate Specific Membrane Antigen in the Diagnosis and Treatment of Prostate Cancer: Status and Challenge.
Journal: OncoTargets and therapy
Published: August 10, 2024
Opportunities and challenges of targeting c-Met in the treatment of digestive tumors.
Journal: Frontiers in oncology
Published: April 19, 2022
CAR-T Cells in the Treatment of Urologic Neoplasms: Present and Future.
Journal: Frontiers in oncology
Published: April 07, 2022
Study on the expression of c-Met in gastric cancer and its correlation with preoperative serum tumor markers and prognosis.
Journal: World journal of surgical oncology
Published: March 30, 2022
Differences in expression of uroplakin III, cytokeratin 7, and cyclooxygenase-2 in canine proliferative urothelial lesions of the urinary bladder.
Journal: Veterinary pathology
Published: March 11, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026